SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000897069-01-500343
Filing Date
2001-08-09
Accepted
2001-08-09 00:00:00
Documents
1
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER - NYMOX PHARMACEUTICAL sdc43a.txt 6-K 48482
  Complete submission text file 0000897069-01-500343.txt   49968
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA, H4M 2V2 A8
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA H4M 2V2 A8 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 1701666
SIC: 2835 In Vitro & In Vivo Diagnostic Substances